@inproceedings{brisou:hal-04344818,
TITLE = {Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry},
AUTHOR = {Brisou, Gabriel and Cartron, Guillaume and Bachy, Emmanuel and Thieblemont, Catherine and Castilla-Llorente, Cristina and Le Bras, Fabien and Gros, Fran{\c c}ois-Xavier and Loschi, Michael and Houot, Roch and Dul{\'e}ry, R{\'e}my and Jardin, Fabrice and Joris, Magalie and Choquet, Sylvain and Morschhauser, Franck and Guidez, St{\'e}phanie and Hermine, Olivier and La Rochelle, Laurianne Drieu and Carras, Sylvain and Guffroy, Blandine and Bories, Pierre and Casasnovas, Ren{\'e}-Olivier and Abraham, Julie and Le Gouill, Steven and Cony-makhoul, Pascale and Gat, Elodie and Tessoulin, Benoit},
URL = {https://hal.science/hal-04344818},
BOOK
TITLE = {65th ASH Annual Meeting},
ADDRESS = {San Diego, United States},
VOLUME = {142},
NUMBER = {Supplement 1},
PAGES = {5138},
YEAR = {2023},
MONTH = Dec, DOI = {10.1182/blood-2023-180241},
KEYWORDS = {Medicine ; Internal medicine ; Salvage therapy ; Regimen ; Lymphoma ; Clinical trial ; Oncology ; Surgery ; Chemotherapy},
HAL_ID = {hal-04344818},
HAL_VERSION = {v1},
}